SandboxAQ was founded in 2016 by Jack Hidary. According to the Wall Street Journal in January 2024, SandboxAQ recently acquired drug company Good Chemistry for $75M. SanboxAQ has not publicly endorsed a plan to participate in an IPO.
SandboxAQ is a developer of AI and quantum computing solutions for commercial applications. Per Forge data, SandboxAQ has raised a total of $500 million in funding over 4 rounds. Their latest funding was raised on Feb 14, 2023. Key investors include Time Ventures, T. Rowe Price, and Breyer Capital.
These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
10/22/2024 | Series E | $500MM | $xx.xx | $599.24B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
29,052,876
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
03/22/2022 | Series D | $466.38MM | $xx.xx | $333.92B | Breyer Capital, Schmidt, Time Ventures, T. Rowe Price | |
Price per Share
$xx.xx
Shares Outstanding
49,463,993
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Breyer Capital, Schmidt, Time Ventures, T. Rowe Price
|